Playback speed
10 seconds
Breakthrough Infections and Predicting Moderate-to-Severe COVID Outcomes During Rituximab Therapy in Rheumatic and Musculoskeletal Diseases
138 views
November 15, 2022
Comments 0
Login to view comments.
Click here to Login
Recommended
AUTOPLAY